Elite soccer players help define normal heart measures in competitive athletes
A new study provides reference standards for clinical evaluations.
Safe Care CommitmentGet the care you need even during COVID-19.Learn more
Corrigan Minehan Heart Center
Contact Us
Corrigan Minehan Heart Center
55 Fruit Street
Boston,
MA
02114
Phone: 866-644-8910
Physicians within the Resynchronization and Advanced Cardiac Therapeutics Program treat patients with heart failure who have diminished heart function and need special pacemaker therapy to synchronize the pumping action of the heart.
This program works through the collaborative efforts of the Heart Failure and Cardiac Transplant Program, the Cardiac Arrhythmia Service and echocardiography services at the Massachusetts General Hospital Corrigan Minehan Heart Center. We also work closely with referring primary cardiologists or internists to ensure continuity of care for patients.
The Resynchronization and Advanced Cardiac Therapeutics Program was established in November of 2005 to provide multidisciplinary care to heart failure patients eligible for device therapy. Care is provided through the collaborative effort and expertise of echocardiography, electrophysiology and heart failure specialists. The program uses research and evidence-based medicine to provide cutting-edge treatment options to patients.
Some of the important objectives of the program are to:
Our goal is to deliver state-of-the-art device therapy to improve the quality of life of our patients.
Most patients are seen for three to four visits to maximize treatment therapies. Our specialists offer a variety of treatments and procedures including:
Cardiac resynchronization therapy is provided for patients with heart failure due to an abnormality in the pumping of the heart's ventricles. The heart's ventricles are supposed to contract simultaneously, but in many patients with heart failure, they may beat out of synchrony.
Care within the Resynchronization and Advanced Cardiac Therapeutics Program truly has no boundaries. Our specialists care for patients in inpatient, outpatient and emergency room settings, as well as follow them remotely in their homes. Bluetooth and radiofrequency (RF) capabilities are typically used in coordination with defibrillator and cardiac resynchronization therapy.
Our physicians have found that cardiac resynchronization therapy can offer patients a number of benefits. Some of these benefits include:
Cardiac resynchronization therapy involves the placement of an implantable biventricular pacing device with three leads (right atrial, right ventricular and left ventricular) that synchronize ventricular contractions. The result is a more efficient heart, and more importantly, a better quality of life for our patients.
This proactive approach saves lives by alerting patients and physicians often before symptoms occur. They receive detailed information on how the heart is beating and can call a patient into the hospital if there is a medical emergency.
Specialists within the Resynchronization and Advanced Cardiac Therapeutics Program have a significant role in several national and international multicenter studies. We have advanced the field of device therapy by:
We are currently seeking participants for the following clinical trials:
Seeking subjects with hypertrophic cardiomyopathy - HCM - (healthy subjects needed)
All Resynchronization and Advanced Cardiac Therapeutics Program physicians are on the faculty of Harvard Medical School, which means they not only have a mission to provide the best possible patient care, but also a commitment to educate the next generation of medical professionals.
Mass General is dedicated to ensuring that people understand their health care choices and have the necessary information to make decisions affecting their health and wellbeing. The related support and wellness information listed below can play a role in treatment options.
Implantable biventricular pacing devices to help synchronize ventricular contractions.
What to expect before, during and after your surgery at the Corrigan Minehan Heart Center.
A guide of what to expect and how to prepare for your procedure.
Mass General is the #1 Research Hospital in America and the only hospital to be recognized in all 16 specialties assessed by U.S. News & World Report.
Our physicians welcome second opinion appointments to review cases and proposed lines of treatment.
A new study provides reference standards for clinical evaluations.
Janet Ma, MD, is a first-year fellow in the Cardiovascular Disease Fellowship Program at Massachusetts General Hospital. Dr. Ma explains what inspired her to come to Mass General, to pursue a career in medicine and her work to improve equity in health care.
Short bursts of physical exercise induce changes in the body’s levels of metabolites that correlate to, and may help gauge, an individual’s cardiometabolic, cardiovascular and long-term health.
New research by investigators at Massachusetts General Hospital (MGH) reveals considerable uncertainty in how to care for patients with a certain type of heart attack.
Study reveals reveals women with premature menopause often exhibit certain blood cell changes that elevate their risk of developing coronary artery disease.
Mass General and Newton-Wellesley Hospital staff have been working together for the past eight months to ensure a safe, efficient and thoughtful transition plan for the more than 600 anticoagulation patients who will now receive their care at the MGH AMS Clinic.
Call us to learn more, or request an appointment online.